Literature DB >> 20298731

Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice.

Deepika Rajesh1, Ying Zhou, Ewa Jankowska-Gan, Drew Allan Roenneburg, Melanie L Dart, Jose Torrealba, William J Burlingham.   

Abstract

We evaluated the immunocompetence of human T cells in humanized NOD-SCID interleukin (IL)-2r-gamma-null (hu-NSG) mice bearing a human thymic organoid, after multilineage reconstitution with isogeneic human leukocytes. Delayed type hypersensitivity (DTH) response was assessed by a direct footpad challenge of the immunized hu-NSG host, or by transfer of splenocytes from immunized hu-NSG, along with antigen, into footpads of C.B-17 scid mice (trans vivo [tv] DTH). Both methods revealed cellular immunity to tetanus toxoid (TT) or collagen type V (ColV). Immunohistochemical analysis of the swollen footpads revealed infiltration of human CD45(+) cells, including CD3(+) T cells, CD68(+) macrophages, and murine Ly6G(+) neutrophils. We observed a significant correlation between the percentage of circulating human CD4(+) cells and the direct DTH swelling response to TT. The tvDTH response to TT was inhibited by anti-interferon-gamma, whereas the tvDTH response to collagen V was inhibited by anti-IL-17 antibody, mimicking the cytokine bias of adult human T cells to these antigens. hu-NSG mice were also capable of mounting a B-cell response (primarily IgM) to TT antigen. The activation of either Th1- or Th17-dependent cellular immune response supports the utility of hu-NSG mice as a surrogate model of allograft rejection and autoimmunity. Copyright 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298731      PMCID: PMC2875879          DOI: 10.1016/j.humimm.2010.02.019

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  21 in total

1.  Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

Authors:  Michael W Melkus; Jacob D Estes; Angela Padgett-Thomas; Joel Gatlin; Paul W Denton; Florence A Othieno; Anja K Wege; Ashley T Haase; J Victor Garcia
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

2.  Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.

Authors:  Ping Lan; Noriko Tonomura; Akira Shimizu; Shumei Wang; Yong-Guang Yang
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

Review 3.  Delayed type hypersensitivity: current theories with an historic perspective.

Authors:  C A Black
Journal:  Dermatol Online J       Date:  1999-05

Review 4.  The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.

Authors:  Mercedes López; Raquel Aguilera; Claudio Pérez; Ariadna Mendoza-Naranjo; Cristian Pereda; Marcos Ramirez; Carlos Ferrada; Juan Carlos Aguillón; Flavio Salazar-Onfray
Journal:  Immunobiology       Date:  2006-01-04       Impact factor: 3.144

5.  A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses.

Authors:  R Laub; M Dorsch; D Meyer; J Ermann; H J Hedrich; F Emmrich
Journal:  J Immunol Methods       Date:  2000-12-01       Impact factor: 2.303

6.  Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols.

Authors:  A Larochelle; J Vormoor; T Lapidot; G Sher; T Furukawa; Q Li; L D Shultz; N F Olivieri; G Stamatoyannopoulos; J E Dick
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

7.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

Authors:  L D Shultz; P A Schweitzer; S W Christianson; B Gott; I B Schweitzer; B Tennent; S McKenna; L Mobraaten; T V Rajan; D L Greiner
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

8.  Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.

Authors:  Angelika B Riemer; Markus Klinger; Stefan Wagner; Astrid Bernhaus; Luca Mazzucchelli; Hubert Pehamberger; Otto Scheiner; Christoph C Zielinski; Erika Jensen-Jarolim
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

9.  Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.

Authors:  Christin M Lepus; Thomas F Gibson; Scott A Gerber; Ivana Kawikova; Marian Szczepanik; Jaber Hossain; Vitaly Ablamunits; Nancy Kirkiles-Smith; Kevan C Herold; Ruben O Donis; Alfred L Bothwell; Jordan S Pober; Martha J Harding
Journal:  Hum Immunol       Date:  2009-06-12       Impact factor: 2.850

10.  HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.

Authors:  Bradford K Berges; William H Wheat; Brent E Palmer; Elizabeth Connick; Ramesh Akkina
Journal:  Retrovirology       Date:  2006-11-01       Impact factor: 4.602

View more
  45 in total

1.  CD95 and CD95L promote and protect cancer stem cells.

Authors:  Paolo Ceppi; Abbas Hadji; Frederick J Kohlhapp; Abhinandan Pattanayak; Annika Hau; Xia Liu; Huiping Liu; Andrea E Murmann; Marcus E Peter
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

Review 2.  Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Trends Microbiol       Date:  2012-04-12       Impact factor: 17.079

3.  Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3.

Authors:  Jeremy A Goettel; Subhabrata Biswas; Willem S Lexmond; Ada Yeste; Laura Passerini; Bonny Patel; Siyoung Yang; Jiusong Sun; Jodie Ouahed; Dror S Shouval; Katelyn J McCann; Bruce H Horwitz; Diane Mathis; Edgar L Milford; Luigi D Notarangelo; Maria-Grazia Roncarolo; Edda Fiebiger; Wayne A Marasco; Rosa Bacchetta; Francisco J Quintana; Sung-Yun Pai; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

Review 4.  Humoral immunity in humanized mice: a work in progress.

Authors:  Edward Seung; Andrew M Tager
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

5.  APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.

Authors:  John F Krisko; Nurjahan Begum; Caroline E Baker; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 6.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 7.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

8.  Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease.

Authors:  Jennifer L Lockridge; Ying Zhou; Yusof A Becker; Shidong Ma; Shannon C Kenney; Peiman Hematti; Christian M Capitini; William J Burlingham; Annette Gendron-Fitzpatrick; Jenny E Gumperz
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-24       Impact factor: 5.742

9.  Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

Authors:  Mirian Mendoza; Angela Ballesteros; Qi Qiu; Luis Pow Sang; Soumya Shashikumar; Sofia Casares; Teodor-D Brumeanu
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

10.  LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

Authors:  Shi-Dong Ma; Xuequn Xu; Julie Plowshay; Erik A Ranheim; William J Burlingham; Jeffrey L Jensen; Fotis Asimakopoulos; Weihua Tang; Margaret L Gulley; Ethel Cesarman; Jenny E Gumperz; Shannon C Kenney
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.